Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1

Molecular Medicine Reports

Volumn 4, Issue 2, 2011, Pages 209-214

  Tsukamoto, Masaya ^a   Hiroi, Satoshi ^b   Adachi, Kazuhide ^a   Kato, Hidenori ^a   Inai, Marie ^a   Konishi, Itsuro ^c   Tanaka, Masaru ^c   Yamamoto, Ryouhei ^c   Sawa, Masaki ^c   Handharyani, Ekowati ^d   Tsukamoto, Yasuhiro ^a  

^a KYOTO PREFECTURAL UNIVERSITY   (Japan)

^b OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c Ostrich Breeding Farm 'Ostrich Kobe'   (Japan)

^d BOGOR AGRICULTURAL UNIVERSITY   (Indonesia)

Author keywords

Antibody; Egg; H1N1; Influenza virus; Ostrich; Pandemic

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN Y; NEUTRALIZING ANTIBODY; SWINE INFLUENZA VACCINE; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CROSS REACTION; CYTOPATHOLOGY; EGG; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE AGGREGATION; FEMALE; IMMUNOCYTOCHEMISTRY; IMMUNOTHERAPY; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; NONHUMAN; OSTRICH; PANDEMIC INFLUENZA; SWINE INFLUENZA VIRUS; VIRUS INHIBITION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; CROSS REACTIONS; DOGS; FEMALE; HUMANS; IMMUNIZATION; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMICS; STRUTHIONIFORMES; SWINE;

ORTHOMYXOVIRIDAE; STRUTHIONIFORMES; SUIDAE; SWINE INFLUENZA VIRUS;

EID: 79551693724     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.410     Document Type: Article

References (20)

1. Alexander DJ and Brown IH: Recent zoonoses caused by influenza A viruses. Rev Sci Tech 19: 197-225, 2000.
2. Rimmelzwaan GF and Osterhaus AD: Influenza vaccine: new developments. Curr Opin Pharmacol 1: 491-496, 2001.
3. Normile D: North Korea collaborates to fight bird flu. Science 308: 175, 2005
4. Center for Disease Control and Prevention (CDC): Experiences with influenza-like illness and attitude regarding influenza prevention. United States, 2003-2004 influenza season. MMWR 53: 1156-1158, 2004
5. Gallaher WR: Towards a sane and rational approach to management influenza H1N1 2009 Virol J 6: 51-59, 2009.
6. Poland GA: Vaccines against avian influenza - a race against time. N Engl J Med 354: 1411-1413, 2006.
7. Sharpe M, Lynch D, Topham, Major D, Wood J and Loudon P: Protection of mice from H5N1 influenza challenge by prophylactic DNA vaccination using particle mediated epidermal delivery. Vaccine 25: 6392-6398, 2007. (Pubitemid 47090232)
8. Wiwanitkit V: N-95 face mask for prevention of bird-flu virus: an appraisal of nanostructure and implication for infectious control. Lung 184: 373-374, 2006.
9. Schade R, Pfister C, Halatsch R and Henklein P: Polyclonal IgY antibodies from chicken egg yolk - an alternative to the production of mammalian IgG type antibodies in rabbits. ATLA 19: 403-419, 1991.
10. Schade R, Schniering A and Hlinak A: Polyclonal avian antibodies extracted from egg yolk as an alternative to the production of antibodies in mammals - a review. ALTEX 9: 43-56, 1992.
11. Gross M and Speck J: Avian yolk antibodies in diagnosis and research. Dtsch Tierarztl Wochenschr 103: 417-422, 1996.
12. Larsson A, Balow RM, Lindahl TL and Forsberg PO: Chicken antibodies: taking advantage of evolution-a review. Poult Sci 72: 1807-1812, 1993.
13. Leslie GA and Clem LW: Phylogeny of immunoglobulin structure and function. III. Immunoglobulins of the chicken. J Exp Med 130: 1337-1352, 1969.
14. Adachi K, Hagimori K, Kato H, Fukuda K, Kikuta M and Tsukamoto Y: Potential role of SC1, a cell adhesion molecule, in mammary gland tumors. Mol Med Rep 1: 219-224, 2008.
15. Adachi K, Handharyani E, Sari DK, Takama K, Fukuda K, Dndo I, Yamamoto R, Sawa M, Tanaka M, Konisi I and Tsukamoto Y: Development of neutralizing antibodies against highly pathogenic H5N1 avian influenza virus using ostrich (Struthio camelus) yolk. Mol Med Rep 1: 203-209, 2008.
16. Reed LJ and Muench H: A simple method of estimating fifity percent endo-points. Am J Hyg 27: 493-797, 1938.
17. Lu L, Yu L and Kwang J: Baculovirus surface-displayed hemagglutinin of H5N1 influenza virus sustains its authentic cleavage, hemagglutination activity, and antigenicity. Biochem Biophys Res Commun 358: 404-409, 2007.
18. Bosch FX, Orlinch M, Klenk HD and Rott R: The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses. Virology 95: 197-207, 1979. (Pubitemid 9171792)
19. Gralton J and McLaws ML: Protecting healthcare workers from pandemic influenza: N95 or surgical masks? Crit Care Med 38: 657-667, 2010.
20. Aiello AE, Murray GF, Perez V, Coulborn RM, Davis BM, Uddin M, Shay DK, Waterman SH and Monto AS: Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. J Infect Dis 201: 491-498, 2010.